Zo Rakotoniaina

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

Pascal Guérard, Zo Rakotoniaina, Françoise Goirand et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2006 · 55 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +14

Metabolomic and Lipidomic Analysis of Serum Samples following Curcuma longa Extract Supplementation in High-Fructose and Saturated Fat Fed Rats

Fabrice Tranchida, Laetitia Shintu, Zo Rakotoniaina et al. · PLoS ONE · 2015 · 43 citations · Full text

Nutrition, Fatty Acids Profiling, Hfs Groups +18

The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin

Zo Rakotoniaina, Pascal Guérard, Frédéric Lirussi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2006 · 37 citations

Hypertension, Hmg-coa Reductase Inhibitors, Pulmonary Arterial Hypertension +15

Long-term high fructose and saturated fat diet affects plasma fatty acid profile in rats

Fabrice Tranchida, Léopold Tchiakpe, Zo Rakotoniaina et al. · Journal of Zhejiang University SCIENCE B · 2012 · 31 citations · Full text

ADRB3 Adrenergic Receptor Is a Key Regulator of Human Myometrial Apoptosis and Inflammation During Chorioamnionitis1

Frédéric Lirussi, Zo Rakotoniaina, Siham Madani et al. · Biology of Reproduction · 2007 · 27 citations